BRCA1 and BRCA 2 mutation predictions using BRACAPRO and MYRIAD models in patients with Korean ethnicity

被引：0
|
作者：
Eoh, Kyung Jin
Park, Hyung Seok
Park, Ji Soo
Lee, Seung-Tae
Han, Jeongwoo
Lee, Jung-Yun
Kim, Sunghoon
Kim, Sang Wun
Kim, Young Tae
Nam, Eun Ji
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-4283
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4283
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The CHEK2 1100delC mutation is not present in Korean patients with breast cancer tested for BRCA1 and BRCA2 mutation
    Choi, D. H.
    Cho, H. Y.
    Lee, M. H.
    Park, H. S.
    Ahn, S. H.
    Haffty, B. G.
    BREAST, 2007, 16 : S14 - S14
  • [22] The Accuracy of BRCA1/2 Mutation Prediction Models in Different Ethnicity and Gender: Experience in a Chinese Cohort
    Kwong, A.
    Wong, C. H. N.
    Suen, D. T. K.
    Choi, C. L. Y.
    Wong, C. L. P.
    Law, F. F. B.
    Kurian, A.
    Ma, E. S. K.
    West, D. W.
    Ford, J. M.
    CANCER RESEARCH, 2010, 70
  • [23] Haplotype analysis of BRCA1/BRCA2 variants in Korean patients with breast cancer
    Kwon, Won Kyung
    Jang, Hyeok-Jae
    Jang, Ja-Hyun
    Lee, Jeong Eon
    Park, Yeon Hee
    Kim, Jong-Won
    GENETIC EPIDEMIOLOGY, 2020, 44 (05) : 489 - 490
  • [24] Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients
    Choi, DH
    Lee, NH
    Bale, AE
    Carter, D
    Haffty, BG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) : 1638 - 1645
  • [25] What is the real IMPACT of BRCA1/BRCA2 mutation?
    Melanie Clyne
    Nature Reviews Urology, 2014, 11 (3) : 124 - 124
  • [26] Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers
    Rebbeck, TR
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S15 - S17
  • [27] The Clinical Management of BRCA1 and BRCA2 Mutation Carriers
    Gulati, Anthony P.
    Domchek, Susan M.
    CURRENT ONCOLOGY REPORTS, 2008, 10 (01) : 47 - 53
  • [28] Cardiovascular Concerns in BRCA1 and BRCA2 Mutation Carriers
    Gast K.C.
    Viscuse P.V.
    Nowsheen S.
    Haddad T.C.
    Mutter R.W.
    Wahner Hendrickson A.E.
    Couch F.J.
    Ruddy K.J.
    Current Treatment Options in Cardiovascular Medicine, 2018, 20 (2)
  • [29] BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families
    Antoniou, AC
    Durocher, F
    Smith, P
    Simard, J
    Easton, DF
    BREAST CANCER RESEARCH, 2006, 8 (01)
  • [30] Clinical management of BRCA1 and BRCA2 mutation carriers
    Domchek, S. M.
    Weber, B. L.
    ONCOGENE, 2006, 25 (43) : 5825 - 5831
12345